Pathfinder Cell Therapy (Pathfinder Cell Therapy) Insider Ownership : 7.26 % (As of Jun. 08, 2024)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pathfinder Cell Therapy's insider ownership is 7.26%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pathfinder Cell Therapy's Institutional Ownership is 0.27%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pathfinder Cell Therapy's Float Percentage Of Total Shares Outstanding is 47.45%.

Pathfinder Cell Therapy Insider Ownership Historical Data

The historical data trend for Pathfinder Cell Therapy's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Insider Ownership Chart

Pathfinder Cell Therapy Historical Data

The historical data trend for Pathfinder Cell Therapy can be seen below:

	2018-02-28	2018-03-31	2018-04-30	2018-05-31	2018-06-30	2018-07-31	2018-08-31	2018-09-30	2018-10-31	2018-11-30
Insider Ownership	7.26	7.26	7.26	7.26	7.26	7.26	7.26	7.26	7.26	7.26

Pathfinder Cell Therapy Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines